Skip to content
About the Library
Rules and Regulations
Library Services
Library Hours
About Us
Library News
Digital Repository
Google Scholar
ResearchGate
AJoGPL
KURJ
AJLS
Research
MyLOFT
Up-to-Date Database
Research Support Tools
Quick Resource Links
E-Resources
Login
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Multicentre, 26-week, open-lab...
Text this
Text this:
Multicentre, 26-week, open-label phase 2 trial of the JAK inhibitor filgotinib in Behçet’s disease, idiopathic inflammatory myopathies and IgG4-related disease: DRIMID study protocol
Number:
Provider:
Select your carrier
Alltel
AT&T
Cricket
Nextel
Sprint
T Mobile
Verizon
Virgin Mobile